Trial intelligence / Profile preview

Topical timolol plus standard wound care vs standard wound care alone after Mohs micrographic surgery

TCTR20260701008Phase 2Recruiting

Sponsor
Mahidol University
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of timolol in cutaneous malignancy, surgical site infection (SSI), sponsored by Mahidol University. Started Dec 2025; status: recruiting.

02

Drugs

timolol
03

Conditions

cutaneous malignancysurgical site infection (SSI)

Beyond the preview

Go deeper on TCTR20260701008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260701008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call